BTA
Click for more information
0.00% 57.0¢ biota holdings limited

lani, iv relenza,flumist breaking news reuters, page-6

  1. autoflight
    850 Posts.
    clock Created with Sketch.
    26/10/09
    13:11
    Post #: 5831106
    Not surprised that GSK abandoned IV Relenza. Their profit is from new vaccines every year. Better for GSK than to find a heap of generic IV Relenza look-a-like vaccine alternatives flooding their market when the patent expires in 2014. GSK cannot serve BTA when it has only one master - GSK.
    BTA Price at posting: $3.12 Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

IMU Imugene doses first cancer patient in Oasis trial
right-arrow Created with Sketch.
GWR Scoping study and Phase 2 drilling progress Prospect Ridge magnesium play for GWR
right-arrow Created with Sketch.
CTT Cettire has launched in China – but can it turn its share price around?
right-arrow Created with Sketch.
MYR Myer lobs proposed merger at major shareholder Premier Investments
right-arrow Created with Sketch.
WAF West African Resources draws final US$100M from Sprott-backed loan for gold plant
right-arrow Created with Sketch.
NEWS Money and Investing: Talking the minefield of divorce & family law
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.